Actavis to get four marketed products from Akorn currently Actavis plc.

Actavis to get four marketed products from Akorn currently Actavis plc , a leading global specialty pharmaceutical business, today announced that it offers entered into agreements with Akorn, Inc. And Hi-Tech Pharmacal Co. Inc. To purchase four marketed products and one item under development for funds consideration currently. The acquisition of the items will complement our expanding portfolio of topical and ophthalmic generic items, and additional strengthen our placement as a innovator in developing and advertising the complex, high-barrier products offering enhanced value, said Siggi Olafsson, President, Actavis Pharma. Â.The survey, insurers and some economists say, displays the sort of irrational pricing of health care that is a fundamental element of the nation’s healthcare problems and that’s mainly being ignored, some state, in the current debate.’ ”It’s the wild, wild West with regards to prices of anything in the U.S. Health care system, whether for a doctor visit or for medical center costs,’ said Jonathan Skinner, a wellness economist at Dartmouth. This article is certainly republished with kind authorization from our friends at The Kaiser Family Foundation. You can view the complete Kaiser Daily Health Plan Record, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, debates and discussions.